{"id":181810,"name":"CEL-SCI CORPORATION","slug":"cel-sci-corporation","state":"VA","country":"United States of America","description":"biotech co. in R&D of immunotherapy products for cancer,autoimmune,and infectious diseases","totalSpending":290000,"filings":8,"yearlySpending":[{"year":2019,"income":100000},{"year":2020,"income":190000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"}],"firms":["THE PETRIZZO GROUP, INC."],"lobbyists":["TJ PETRIZZO","MEGAN PEREZ BURKE"],"govEntities":["Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","Office of Management & Budget (OMB)","SENATE","Natl Institutes of Health (NIH)","Vice President of the U.S."],"sampleDescriptions":["FDA approval issues of innovative drug therapies","FDA approval issues of innovative drug therapies","Activity related to phase III clinical trial in head and neck cancer to boost the immune system before the ravages of surgery, radiation and chemotherapy. The Phase III trial is the largest ever in he","Activity related to phase III clinical trial in head and neck cancer to boost the immune system before the ravages of surgery, radiation and chemotherapy. The Phase III trial is the largest ever in he","Activity related to phase III clinical trial in head and neck cancer to boost the immune system before the ravages of surgery, radiation and chemotherapy. The Phase III trial is the largest ever in he"]}